Show
Sort by
-
- Journal Article
- A1
- open access
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC) : a randomised controlled trial
-
- Journal Article
- A1
- open access
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
-
- Journal Article
- A1
- open access
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19 : an economic evaluation of the PANORAMIC trial